TY - JOUR
T1 - Impairment of protease-activated receptor 2-induced relaxation of aortas of aged spontaneously hypertensive rat
AU - Ando, Makoto
AU - Matsumoto, Takayuki
AU - Kobayashi, Shota
AU - Iguchi, Maika
AU - Taguchi, Kumiko
AU - Kobayashi, Tsuneo
N1 - Funding Information:
Acknowledgments We thank Mr. K. Takayanagi, Mrs. M. Kojima, Mr. M. Ichikawa, Mrs. M. Iwasaki, Mr. S. Ohira, Mrs. K. Taguchi, Mr. S. Noguchi, Mrs. K. Hatano, and Mrs. Y. Higashida for technical assistance. This study was supported in part by JSPS KAKENHI Grants JP17K07975 to K.T. and JP15K07975 to T.K.
Publisher Copyright:
© 2018 The Pharmaceutical Society of Japan.
PY - 2018
Y1 - 2018
N2 - Hypertension is one of the most prevalent diseases worldwide and can cause harmful complications within the vascular system. Further research on vascular responsiveness to different ligands and diverse receptors in various arteries is required to understand the mechanisms underlying the development of these vascular complications. Here, we investigated the vasorelaxant effect of the protease-activated receptor 2 (PAR2) agonist 2-furoyl-LIGRLO-amide (2-Fly) and two commonest agents, namely endothelium-dependent dilator acetylcholine (ACh) and endothelium-independent dilator sodium nitroprusside (SNP), on the thoracic aorta isolated from aged spontaneously hypertensive rats (SHR) (age, 52±1 weeks). The effects of these agents were compared between aortas isolated from SHR and age-matched normotensive Wistar Kyoto (WKY) rats. Compared with the WKY group, in the SHR group, 2-Fly-induced relaxation was impaired, ACh-induced relaxation was slightly decreased at low concentrations, and SNP-induced relaxation was similar. In addition, 2-Fly-induced aortic relaxation was largely decreased by a PAR2 antagonist (FSLLRY), endothelial denudation, and a nitric oxide (NO) synthase inhibitor NG-nitro-L-arginine (L-NNA) but not by an Akt inhibitor. These results suggested that PAR2-induced relaxations of aortas of aged SHR was impaired, and this impaired aortic relaxation may be attributed to decreased NO bioavailability rather than altered NO sensitivity unrelated to the Akt activity.
AB - Hypertension is one of the most prevalent diseases worldwide and can cause harmful complications within the vascular system. Further research on vascular responsiveness to different ligands and diverse receptors in various arteries is required to understand the mechanisms underlying the development of these vascular complications. Here, we investigated the vasorelaxant effect of the protease-activated receptor 2 (PAR2) agonist 2-furoyl-LIGRLO-amide (2-Fly) and two commonest agents, namely endothelium-dependent dilator acetylcholine (ACh) and endothelium-independent dilator sodium nitroprusside (SNP), on the thoracic aorta isolated from aged spontaneously hypertensive rats (SHR) (age, 52±1 weeks). The effects of these agents were compared between aortas isolated from SHR and age-matched normotensive Wistar Kyoto (WKY) rats. Compared with the WKY group, in the SHR group, 2-Fly-induced relaxation was impaired, ACh-induced relaxation was slightly decreased at low concentrations, and SNP-induced relaxation was similar. In addition, 2-Fly-induced aortic relaxation was largely decreased by a PAR2 antagonist (FSLLRY), endothelial denudation, and a nitric oxide (NO) synthase inhibitor NG-nitro-L-arginine (L-NNA) but not by an Akt inhibitor. These results suggested that PAR2-induced relaxations of aortas of aged SHR was impaired, and this impaired aortic relaxation may be attributed to decreased NO bioavailability rather than altered NO sensitivity unrelated to the Akt activity.
KW - Aorta
KW - Endothelium
KW - Hypertension
KW - Protease-activated receptor 2 (PAR2)
KW - Relaxation
UR - http://www.scopus.com/inward/record.url?scp=85046699091&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046699091&partnerID=8YFLogxK
U2 - 10.1248/bpb.b17-00987
DO - 10.1248/bpb.b17-00987
M3 - Article
C2 - 29709920
AN - SCOPUS:85046699091
SN - 0918-6158
VL - 41
SP - 815
EP - 819
JO - Biological and Pharmaceutical Bulletin
JF - Biological and Pharmaceutical Bulletin
IS - 5
ER -